Women Exposed to DES in Utero Have Elevated Risk of Clear-Cell Adenocarcinoma


Hannah K. Weir, an epidemiologist with the CDC, summarizes her study published in Springer Link.


Women exposed to diethylstilbestrol (DES) in utero were at elevated risk of clear-cell adenocarcinoma of the vagina and cervix (CCA) as young women. Previous research suggested that this elevated risk of CCA may persist into adulthood. We extended a published analysis to measure CCA risk as these women aged.


Standardized incidence ratios (SIR) compared CCA risk among women born from 1947 through 1971 (the DES-era) to CCA risk among the comparison group of women born prior to 1947, using registry data that covered the U.S. population.


Incidence rates of CCA among both cohorts increased with age. Among the DES-era birth cohort, higher rates of CCA were observed across all age groups except 55-59 years. SIR estimates had wide confidence intervals that often included the null value.


Results are consistent with prior research and suggest an elevated risk of CCA in midlife and at older ages among women exposed in utero to DES. These results highlight unresolved issues regarding cancer risk among aging DES daughters and appropriate screening guidance. The examination of population-based cancer surveillance data may be a useful tool for monitoring trends in the incidence of other rare cancers over time among specific birth cohorts.

View the study about DES and clear-cell adenocarcinoma of the vagina and cervix among young women who were exposed in utero.

What to Read Next

Early Stage Detection of Cervical Cancer Improves Survival for Women Under 65

Julianne Cooley, a senior statistician with the California Cancer Reporting and Epidemiologic Surveillance Program, summarizes her study published in the…

Transitioning the Annotated Histology List to Cancer PathCHART

NAACCR is proud to be involved with Cancer PathCHART, a multi‐organizational project alongside eleven other global organizations.

Data Modernization in Action: Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act

The STAR Project is part of the CDC’s bigger picture for data modernization. The Childhood Cancer Survivorship, Treatment, Access, and…